Omeros Corp
Change company Symbol lookup
Select an option...
OMER Omeros Corp
FSLR First Solar Inc
SHOO Steven Madden Ltd
FISV Fiserv Inc
UFI Unifi Inc
SSTK Shutterstock Inc
CSGP CoStar Group Inc
OBELF Obsidian Energy Ltd
RCKY Rocky Brands Inc
HSBC HSBC Holdings PLC
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Omeros Corporation is a commercial-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases and disorders of the central nervous system. The Company’s drug product OMIDRIA (phenylephrine and ketorolac intraocular solution) is used during cataract surgery or intraocular lens (IOL) replacement. The Company’s clinical-stage development programs are focused on complement-associated thrombotic microangiopathies, complement-mediated glomerulonephropathies, Huntington’s disease and cognitive impairment, and addictive and compulsive disorders. It also offers a diverse group of preclinical programs and platforms that are used to unlock new G protein-coupled receptor (GPCR) drug targets and to generate antibodies.

Closing Price
$10.54
Day's Change
0.32 (3.13%)
Bid
--
Ask
--
B/A Size
--
Day's High
10.65
Day's Low
10.02
Volume
(Average)
Volume:
560,034

10-day average volume:
614,388
560,034
  • Prev Close
    10.22
  • Today's Open
    10.17
  • Day's Range
    10.02-10.65
  • Avg Vol (10-day)
    614.4K
  • Last (time)
    4:00p ET 10/27/20
  • Last (size)
    10.1K
  • 52-Wk Range
    8.50 - 25.46
    LowHigh
  • (03/16/20 - 08/10/20)
    24.00%
  • 101.3%
  • Market Cap
    647.3M
  • Shares Outstanding
    61.4M
  • -2.06
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.6
  • 49.94
  • (% of float 10/15/20)
    21.44

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.